Clinical Updates
Drug approvals, guideline changes, and treatment advances
Blood test with circular RNA markers predicts Alzheimer’s disease years before symptoms emerge
A blood test measuring 34 circular RNA markers predicts Alzheimer's disease progression with 92% accuracy, outperforming current protein biomarkers and…
Editor's Top Picks
University of Queensland Drug Targets Immune Receptor, Offering Hope for Motor Neuron Disease
Researchers at the University of Queensland have developed a novel drug that activates a previously difficult-to-target immune receptor, a breakthrough…
Submit Your Paper →
More form Clinical Updates
Diclegis Access Crisis: Why a Proven Pregnancy Nausea Drug Remains Out of Reach for Many NHS Patients
A clinically approved pregnancy nausea medication remains inconsistently available across NHS trusts, with some regions…
Medical Groups Warn Gender-Affirming Care Bans Undermine Child Safety, Not Protect It
Physicians warn that legislative bans on gender-affirming care for transgender youth undermine clinical safety by…
First oral drug shows promise in childhood achondroplasia: Phase 3 trial results
A Phase 3 trial published in the New England Journal of Medicine shows that oral…
One in three young adults lack a primary care doctor, survey finds
A survey by Ohio State University Wexner Medical Center reveals that approximately 30% of young…
Expanding Heart Failure Care With Pharmacists and Nurse Practitioners Cuts Costs and Saves Lives
An economic analysis in the Canadian Journal of Cardiology demonstrates that integrating pharmacists and nurse…